HK2 and hepatocellular carcinoma: Chen et al. demonstrated that HK2 accelerates glycolysis in HBx-induced HCC via the NF-κB p65 signaling pathway, while further supporting tumor growth through the activation of the PI3K/Akt pathway 165.